Managed  	Managed  	 VBN	B-NP
care  	care  	 NN	I-NP
&  	&  	 CC	O
medical  	medical  	 JJ	B-NP
oncology 	oncology 	 NN	I-NP
:  	:  	 :	O
the  	the  	 DT	O
focus  	focus  	 NN	O
is  	is  	 VBZ	O
on  	on  	 IN	O
value  	value  	 NN	O
A  	A  	 DT	O
previous  	previous  	 JJ	O
NCCN  	NCCN  	 NNP	B-NP
Oncology  	Oncology  	 NNP	I-NP
Insights  	Insights  	 NNPS	I-NP
Reportdescribed  	Reportdescribed  	 NNP	O
the  	the  	 DT	O
factors  	factors  	 NNS	O
making  	making  	 VBG	B-NP
cancer  	cancer  	 NN	I-NP
care  	care  	 NN	I-NP
a  	a  	 DT	O
priority  	priority  	 NN	O
for  	for  	 IN	O
managed  	managed  	 JJ	O
care  	care  	 NN	B-NP
organizations  	organizations  	 NNS	I-NP
( 	( 	 -LRB-	O
MCOs 	MCOs 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
emerging  	emerging  	 VBG	B-NP
trends  	trends  	 NNS	I-NP
in  	in  	 IN	O
managing  	managing  	 VBG	B-NP
costs  	costs  	 NNS	I-NP
of  	of  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
care 	care 	 NN	I-NP
.  	.  	 .	O
To  	To  	 TO	O
better  	better  	 RB	O
understand  	understand  	 VB	O
the  	the  	 DT	O
concerns  	concerns  	 NNS	O
of  	of  	 IN	O
MCOs  	MCOs  	 JJ	O
and  	and  	 CC	O
how  	how  	 WRB	O
they  	they  	 PRP	O
are  	are  	 VBP	O
addressing  	addressing  	 VBG	B-NP
cancer  	cancer  	 NN	I-NP
costs  	costs  	 NNS	I-NP
and  	and  	 CC	O
quality 	quality 	 NN	O
,  	,  	 ,	O
NCCN  	NCCN  	 NNP	B-NP
interviewed  	interviewed  	 VBD	O
senior  	senior  	 JJ	O
physician  	physician  	 NN	O
executives  	executives  	 NNS	O
from  	from  	 IN	O
the  	the  	 DT	O
3  	3  	 CD	O
largest  	largest  	 JJS	O
payors  	payors  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States 	States 	 NNPS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
interviews  	interviews  	 NNS	O
provided  	provided  	 VBD	B-NP
insights  	insights  	 VBN	I-NP
into  	into  	 IN	O
how  	how  	 WRB	O
these  	these  	 DT	O
companies  	companies  	 NNS	O
managed  	managed  	 VBD	O
oncology  	oncology  	 JJ	B-NP
care 	care 	 NN	I-NP
,  	,  	 ,	O
with  	with  	 IN	O
an  	an  	 DT	O
emphasis  	emphasis  	 NN	O
on  	on  	 IN	O
drugs  	drugs  	 NNS	O
and  	and  	 CC	O
biologics 	biologics 	 NN	B-NP
.  	.  	 .	O
As  	As  	 IN	O
a  	a  	 DT	O
follow-up  	follow-up  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
previous  	previous  	 JJ	O
report 	report 	 NN	O
,  	,  	 ,	O
NCCN  	NCCN  	 NNP	B-NP
conducted  	conducted  	 VBD	O
additional  	additional  	 JJ	O
interviews  	interviews  	 NNS	O
with  	with  	 IN	O
medical  	medical  	 JJ	B-NP
executives  	executives  	 NNS	I-NP
from  	from  	 IN	O
10  	10  	 CD	O
MCOs  	MCOs  	 NN	B-NP
between  	between  	 IN	O
February  	February  	 NNP	O
and  	and  	 CC	O
April  	April  	 NNP	O
2010 	2010 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
organizations  	organizations  	 NNS	B-NP
represented  	represented  	 VBD	O
in  	in  	 IN	O
these  	these  	 DT	O
interviews  	interviews  	 NNS	O
were  	were  	 VBD	O
Aetna 	Aetna 	 NNP	B-NP
,  	,  	 ,	O
BlueCross  	BlueCross  	 JJ	B-NP
BlueShield  	BlueShield  	 NN	I-NP
of  	of  	 IN	I-NP
Minnesota 	Minnesota 	 NNP	I-NP
,  	,  	 ,	O
BlueShield  	BlueShield  	 JJ	O
of  	of  	 IN	O
Michigan 	Michigan 	 NNP	B-NP
,  	,  	 ,	O
CareFirst  	CareFirst  	 JJ	B-NP
BlueCross  	BlueCross  	 JJ	I-NP
BlueShield 	BlueShield 	 NN	I-NP
,  	,  	 ,	O
Empire  	Empire  	 NNP	B-NP
BlueCross  	BlueCross  	 NNP	I-NP
BlueShield 	BlueShield 	 NNP	I-NP
,  	,  	 ,	O
HealthNow 	HealthNow 	 NNP	B-NP
,  	,  	 ,	O
Humana 	Humana 	 NNP	B-NP
,  	,  	 ,	O
Independence  	Independence  	 NNP	B-NP
BlueCross 	BlueCross 	 NNP	I-NP
,  	,  	 ,	O
Priority  	Priority  	 NNP	O
Health 	Health 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
UnitedHealthcare 	UnitedHealthcare 	 JJ	O
.  	.  	 .	O
Although  	Although  	 IN	O
this  	this  	 DT	O
group  	group  	 NN	O
is  	is  	 VBZ	O
diverse 	diverse 	 JJ	O
,  	,  	 ,	O
it  	it  	 PRP	O
does  	does  	 VBZ	O
not  	not  	 RB	O
constitute  	constitute  	 VB	O
a  	a  	 DT	O
representative  	representative  	 JJ	B-NP
cross-section  	cross-section  	 NN	I-NP
of  	of  	 IN	O
MCOs  	MCOs  	 JJ	O
across  	across  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States 	States 	 NNPS	I-NP
.  	.  	 .	O
NCCN  	NCCN  	 NNP	B-NP
interviewed  	interviewed  	 VBD	O
these  	these  	 DT	O
executives  	executives  	 NNS	O
about  	about  	 IN	O
the  	the  	 DT	O
priority  	priority  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	B-NP
care  	care  	 NN	I-NP
management  	management  	 NN	I-NP
for  	for  	 IN	O
their  	their  	 PRP$	O
organizations  	organizations  	 NNS	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
strategies  	strategies  	 NNS	O
being  	being  	 VBG	O
used  	used  	 VBN	O
to  	to  	 TO	O
address  	address  	 VB	O
cost  	cost  	 NN	O
and  	and  	 CC	O
quality  	quality  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	B-NP
care 	care 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
information  	information  	 NN	B-NP
garnered  	garnered  	 NN	I-NP
from  	from  	 IN	O
these  	these  	 DT	O
interviews  	interviews  	 NNS	O
was  	was  	 VBD	O
qualitative  	qualitative  	 VBN	O
in  	in  	 IN	O
nature 	nature 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
separate  	separate  	 JJ	O
quantitative  	quantitative  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
of  	of  	 IN	O
trends  	trends  	 NNS	O
in  	in  	 IN	O
oncology  	oncology  	 JJ	B-NP
managed  	managed  	 JJ	I-NP
care  	care  	 NN	I-NP
has  	has  	 VBZ	O
already  	already  	 RB	O
been  	been  	 VBN	O
published 	published 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
throughout  	throughout  	 IN	O
this  	this  	 DT	O
report 	report 	 NN	O
,  	,  	 ,	O
data  	data  	 NNS	O
from  	from  	 IN	O
the  	the  	 DT	O
2009-2010  	2009-2010  	 NNP	O
Genentech  	Genentech  	 NNP	B-NP
Oncology  	Oncology  	 NNP	I-NP
Trend  	Trend  	 NNP	I-NP
Report  	Report  	 NNP	I-NP
are  	are  	 VBP	O
referenced  	referenced  	 VBN	O
to  	to  	 TO	O
supplement  	supplement  	 VB	O
findings  	findings  	 NNS	O
from  	from  	 IN	O
the  	the  	 DT	O
NCCN  	NCCN  	 NNP	B-NP
interviews 	interviews 	 NNS	I-NP
.  	.  	 .	O
